PACLX
Price
$36.88
Change
+$0.03 (+0.08%)
Updated
Aug 7 closing price
Net Assets
69.13B
RPBAX
Price
$28.37
Change
+$0.04 (+0.14%)
Updated
Aug 7 closing price
Net Assets
4.83B
Interact to see
Advertisement

PACLX vs RPBAX

Header iconPACLX vs RPBAX Comparison
Open Charts PACLX vs RPBAXBanner chart's image
T. Rowe Price Capital Appreciation Adv
Price$36.88
Change+$0.03 (+0.08%)
VolumeN/A
Net Assets69.13B
T. Rowe Price Balanced
Price$28.37
Change+$0.04 (+0.14%)
VolumeN/A
Net Assets4.83B
PACLX vs RPBAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PACLX vs. RPBAX commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PACLX is a Buy and RPBAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PACLX has more cash in the bank: 69.1B vs. RPBAX (4.83B). RPBAX pays higher dividends than PACLX: RPBAX (2.00) vs PACLX (1.78). PACLX was incepted earlier than RPBAX: PACLX (21 years) vs RPBAX (86 years). PACLX (1.00) is less costly to investors than RPBAX (0.65). PACLX is a more actively managed with annual turnover of: 85.00 vs. RPBAX (39.20). PACLX (2500) and RPBAX (2500) have matching initial minimum investment requirements. RPBAX annual gain was more profitable for investors over the last year : 9.20 vs. PACLX (6.27). RPBAX return over 5 years is better than : 20.27 vs. PACLX (19.13).
PACLXRPBAXPACLX / RPBAX
Total Expense Ratio0.970.60162%
Annual Report Gross Expense Ratio1.000.65154%
Fund Existence21 years86 years-
Gain YTD8.2558.97892%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets69.1B4.83B1,429%
Annual Yield % from dividends1.782.0089%
Returns for 1 year6.279.2068%
Returns for 3 years13.9523.8458%
Returns for 5 years19.1320.2794%
Returns for 10 years50.6541.65122%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STVN24.200.15
+0.62%
Stevanato Group SpA
REGCP23.51N/A
N/A
Regency Centers Corp
DAN17.57-0.05
-0.28%
Dana
STRO0.80-0.02
-2.16%
Sutro Biopharma
MCFT19.45-0.54
-2.70%
MasterCraft Boat Holdings